Evidence map›Paper›PMID 41977542›Full record

ArticlePolymers2026

Scalable Nanoemulsion Formation of Lipophilic Active Ingredients via Low-Energy Phase Inversion.

Ji-Hyeon Kim, Su-Hwa Son, Hye Won Lee, Jae Hun Kim, Sung-Min Kang, Chang-Hyung Choi

Abstract read
In one paragraph

Article in Polymers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ji-Hyeon KimSchool of Chemical Engineering, Yeungnam University, 280, Daehak-ro, Gyeongsan 38541, Gyeongbuk, Republic of Korea.ORCID 0009-0008-0037-8819
Su-Hwa SonSchool of Chemical Engineering, Yeungnam University, 280, Daehak-ro, Gyeongsan 38541, Gyeongbuk, Republic of Korea.ORCID 0009-0001-2797-2665
Hye Won LeeMR Innovation Co., Ltd., 129, Alphacity 1-ro, Suseong-gu, Daegu 42251, Gyeongbuk, Republic of Korea.
Jae Hun KimMR Innovation Co., Ltd., 129, Alphacity 1-ro, Suseong-gu, Daegu 42251, Gyeongbuk, Republic of Korea.
Sung-Min KangDepartment of Green Chemical Engineering, Sangmyung University, Cheonan 31066, Chungnam, Republic of Korea.ORCID 0000-0001-5758-2628
Chang-Hyung ChoiSchool of Chemical Engineering, Yeungnam University, 280, Daehak-ro, Gyeongsan 38541, Gyeongbuk, Republic of Korea.ORCID 0000-0002-7561-3720

Funding

Korea Health Industry Development Institute RS-2025-02214418Korea SMEs and Startups Agency RS-2025-02307626Ministry of Education 2025-RISE-12-011Ministry of Food and Drug Safety 25192MFDS001National Research Foundation of Korea RS-2024-00346302National Research Foundation of Korea RS-2025-02233102
6 · The paper itself

Abstract

Nanoemulsions are widely recognized as versatile delivery platforms capable of stably loading lipophilic active ingredients. Although low-energy phase inversion methods enable nanoemulsion formation under ambient and low-shear conditions, their scalability and applicability in practical formulation environments remain insufficiently validated. Here, we develop oil-in-water (O/W) nanoemulsions via a low-energy phase inversion process and systematically investigate their composition-dependent formation, scalability, and formulation stability. By precisely tuning the composition of a mixed nonionic surfactant system, monodisperse nanoemulsions with an average droplet size of ~110 nm and a polydispersity index (PDI ≤ 0.20) are reproducibly obtained under ambient, low-shear conditions. The optimized nanoemulsions maintain their nanoscale dispersion characteristics over 30 days of storage and exhibit consistent droplet size and distribution upon scale-up to 1 L. Furthermore, the nanoemulsions retain structural stability when incorporated into polymer-based formulations under various temperature conditions and repeated thermal cycling. These results demonstrate that low-energy phase inversion enables a scalable and formulation-compatible nanoemulsion platform, providing practical guidelines for industrial formulation and manufacturing of delivery systems for lipophilic active ingredients.

Indexed as

lipophilic active deliverylow-energy phase inversionnanoemulsionpolymer-based formulationscalable emulsificationthermal stability

Identifiers

PMID41977542
PMCPMC13074364

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.